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A B S T R A C T
Glioblastoma is a kind of malignant tumour and originates from the central nervous system. In the last century,
some researchers and clinician have noticed that the psychosocial and neurocognitive functioning of patients
with malignant gliomas can be impaired. Many clinical studies have demonstrated that part of patients, adults or
children, diagnosed with glioblastoma will suffer from cognitive deficiency during their clinical course, espe-
cially in long-term survivors. Many nanoparticles (NPs) can inhibit the biological functions of tumours by
modulating tumour-associated inflammation, which provokes angiogenesis and tumour growth. As one of the
best antiviral nanoparticles (AVNPs), AVNP2 is the 2nd generation of AVNP2 that have been conjugated to
graphite-graphene for improving physiochemical performance and reducing toxicity. AVNP2 inactivates viruses,
such as the H1N1 and H5N1influenza viruses and even the SARS coronavirus, while it inhibits bacteria, such as
MRSA and E. coli. As antimicrobials, nanoparticles are considered to be one of the vectors for the administration
of therapeutic compounds. Yet, little is known about their potential functionalities and toxicities to the neu-
rotoxic effects of cancer. Herein, we explored the functionality of AVNP2 on inhibiting C6 in glioma-bearing rats.
The novel object-recognition test and open-field test showed that AVNP2 significantly improved the neuro-
behaviour affected by C6 glioma. AVNP2 also alleviated the decline of long-term potentiation (LTP) and the
decreased density of dendritic spines in the CA1 region induced by C6. Western blot assay and immuno-
fluorescence staining showed that the expressions of synaptic-related proteins (PSD-95 and SYP) were increased,
and these findings were in accordance with the results mentioned above. It revealed that the sizes of tumours in
C6 glioma-bearing rats were smaller after treatment with AVNP2. The decreased expression of inflammatory
factors (IL-1β, IL-6 and TNF-α) by Western blotting assay and ELISA, angiogenesis protein (VEGF) by Western
blotting assay and other related proteins (BDNF, NF-ĸB, iNOS and COX-2) by Western blotting assay in peri-
tumour tissue indicated that AVNP2 could control tumour-associated inflammation, thus efficiently ameliorating
the local inflammatory condition and, to some extent, inhibiting angiogenesis in C6-bearing rats. In conclusion,
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our results suggested that AVNP2 could have an effect on the peri-tumor environment, obviously restraining the
growth progress of gliomas, and eventually improving cognitive levels in C6-bearing rats.
1. Introduction
Glioblastoma (GBM), a kind of tumour originating from neural stem
cells, glial progenitors and astrocytes in the central nervous system, is
the most malignant subtype of glioma (Zong et al., 2012; Ohgaki and
Kleihues, 2005). It has attracted the attention of researchers all over the
world for its highly aggressive characteristics, high recurrence rate and
high mortality (Graus et al., 2013; Tanaka et al., 2013). At present,
surgery combined with radiotherapy and chemotherapy is the most
common treatment strategy in clinic (Stupp et al., 2017; Okada et al.,
2017). However, the tolerance of tumour cells to therapy makes some
residual lesions regrow, so the outcomes have not been satisfactory
(Stupp et al., 2009). Furthermore, it has been found that cognitive
impairment is one of the most important clinical symptoms and com-
plications of craniocerebral disease in both patients and animal models
with gliomas (Solanki et al., 2017; Wang et al., 2011; Weitzner and
Meyers, 1997; Van Dyk and Ganz, 2019). Cognitive function occupies
an essential position in predicting the prognosis of glioma patients and
may even be the first indicator of tumour recurrence after treatment
(Crossen et al., 1994; Janelsins et al., 2011; Vecht et al., 2017; Jacob
et al., 2018). In addition, metabolic disorders and tumour regeneration
may have a negative impact on cognitive function (Williams et al.,
2015; Quant et al., 2009). The cognitive impairment caused by the side
effects of radiotherapy and chemotherapeutic drugs is prone to the
whole cerebral hemisphere (Froklage et al., 2014; Hilverda et al.,
2010). Thus, it is important to create some new therapies and develop
some new drugs to repair patients' cognitive impairment.
The micro-environment of glioma consists of various types of cells,
of which microglia and tumour-associated macrophages (TAMs) are
two important cells. They aggregate in and around glioma tissue and
participate in the proliferation and invasion of tumour cells (Noy and
Pollard, 2014; Wu and Watabe, 2017). There exists a positive correla-
tion between the level of inflammatory cytokines inside the tumour
micro-environment (TME) and the poor clinical prognosis of patients
(Sorensen et al., 2018). Modulating the local inflammatory response has
become a new strategy for immunotherapy due to its vital role in the
development of tumours (Graf et al., 2002; Mineharu et al., 2011). Pro-
inflammatory cytokines, including interleukin-6 (IL)-6, IL-1β and tu-
mour necrosis factor-α (TNF)-α that promote tumour proliferation and
migration and NF-ĸB pathway play important roles in this process
(Mostofa et al., 2017; McFarland et al., 2013; Myung et al., 2010).
Therefore, drugs and related therapies devoted to modulating peri-tu-
mour inflammation in the treatment of glioblastoma have massive po-
tential both now and in the future.
Some metallic nanoparticles (NPs) and their intermetallics can form
graphite-graphene conjugates to produce strong antiviral/antimicrobial
abilities and they are considered to be antiviral and antimicrobial na-
noparticles (AVNPs/AMNPs) (Cheong et al., 2017). These AVNPs/
AMNPs offer promising biomedical applications, including as anti-
microbial agents in the environment (e.g, inactivating the H1N1 and
H5N1 influenza viruses and the SARS coronavirus) or as vectors for the
administration of therapeutic compounds or for the delivery of specific
drug (Ren, 2010, 2013). Yet, little is known about the potential and
wider spectrum of neuronal cell function, neurotoxic effects to cells or
specifically to neuronal cancer cells (Yang et al., 2010).
It has been proved that AMNPs and AVNPs, such as Ag(Ag+), Cu
(Cu2+) and Zn(Zn2+), have been developed with proven efficacy
(99.999%) against both Gram-positive (G+) and Gram-negative (G−)
bacteria (Cheong et al., 2017; Ren et al., 2009; Bankier et al., 2018),
which is similar or close to antibiotic properties in-vitro (Wan et al.,
2016). The nano-intermetallics (i.e., AVNP2) can especially effectively
inactivate bacteria and inhibit bacterial biofilm formation through ionic
releases (0.1–5 ppm of [Cu2+-[Ag+]) enhanced by their surface charge
(Zeta protentional (<−40 mv (Nan et al., 2016; Nan et al., 2015; Ren,
2015, 2016) and surface free energy (> 70 mJ/m2) (Nan et al., 2015)
Terahertz (THz) radiation (He et al., 2018) is useful for a number of
scientific and industrial applications, such as molecular spectroscopy,
high data-rate communication, and material studies. In particular, ter-
ahertz (THz) imaging as one of the candidate technologies for medical
imaging has attracted great attention in recent years due to its prop-
erties of fingerprint spectrum, safety, and water sensitivity. The re-
search on THz biological imaging has been used in various medical
fields, such as dermatology and oncology (Sim et al., 2013; Woodward
et al., 2003; Reid et al., 2011; Park et al., 2017). In the field of neu-
rosurgery, investigations of gliomas using THz spectrum and THz re-
flection imaging have also been reported for post-processed, fresh ex
vivo and in vivo brain tissues (Park et al., 2017; Oh et al., 2014; Meng
et al., 2014; Wu et al., 2019). However, reflection imaging is always
affected by diffusive reflections because of the uneven surface of the
sample. Attenuated total reflection (ATR) can provide information on
the interaction between the sample and evanescent waves traveling
along a prism’s surface. Thus, ATR imaging can obtain the precise ab-
sorption information of the tissue without inevitable noises.
In this paper, we focused on exploring THz ATR imaging to dis-
criminate tumour from normal brain tissue. We demonstrated that tu-
mours in freshly excised whole brain tissue could be clearly differ-
entiated from normal brain tissue using this imaging system.
Antiviral nanoparticle 2(AVNP2) is an antiviral nanomaterial,
which has been shown to kill the SARS virus in vitro (Ren et al., 2013).
With increasing studies on the application of nanomaterials in the im-
munotherapy of tumours, a great deal of reports have been published
suggesting that nanomaterials can inhibit TAMs to detain the release of
related inflammatory factors to achieve the inhibition of tumour growth
(Ovais et al., 2019; Gong et al., 2019; Reichel et al., 2019). Thus, we
hypothesised that AVNP2 can inhibit the proliferation of C6 glioma
cells in rats and can in turn further improve the cognitive impairment of
C6 model rats in terms of tumour cell reduction.
As a result, in this study, we proved that AVNP2 could rescued the
cognitive impairment of C6 glioma-bearing rats by restraining peri-tu-
mour inflammation and impede the growth of tumour cells.
2. Materials and methods
2.1. Cell culture
C6 glioma cells (ATCC, USA) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Gibco BRL, USA) with antibiotics and 10%
foetal calf serum. Culture media was placed in the environment with a
humidified atmosphere of 5% carbon dioxide (CO2)/98% air, and the
temperature was maintained at 37 °C. When the cultures became 80%-
90% confluent, they were washed by phosphate-buffered saline (PBS).
Afterwards, C6 cells were suspended in DMEM at the concentration of
1.0 × 106 cells per 10 μl in a tube for brain tumour xenograft.
2.2. Materials
The AVNP2 used in this study was acquired from the
Antimicrobials@UH team, representing the AVNP Consortium in the
UK, Institute of Science and Technology, University of Hertfordshire,
Hatfield, UK. The transmission electron microscopy (TEM) of the
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structure of AVNP2 is shown in Fig. 1. As indicated in the TEM, the
paralleled chemical analysis that measuring the AVNP2 nanoparticles
was carried out by research groups elsewhere using multiple analytical
instruments including XPS, FTIR, Raman Spectroscopy, Solid State
Carbon-13 Nuclear Magnetic Resonance spectroscopy, Powder X-ray
Diffraction and X-Ray Photoelectron Spectroscopy (Ren et al., 2009;
Cheong et al., 2017). AVNP2 was suspended in saline solution (0.9%
NaCl) at a concentration of 1 mg/ml, and the suspension was sonicated
for 10 min before injection into the brain.
2.3. Animals
Specific-pathogen free adult male Sprague-Dawley (SD) rats,
weighing 250–300 g, were purchased from the Experimental Animal
Centre at the Chinese Academy of Medical Science. Before the experi-
ments, they were kept in an animal house allocated at the Medical
School of Nankai University. They were receiving common feed and
water (5 rats in each cage) at a room temperature (RT) of 20 ± 2 °C
and 12 h light/dark cycle per day based on the regulations and stan-
dards required. All experiments conformed to the protocols ratified by
the Committee for Animal Care at Nankai University and corresponded
to the practices outlined in the NIH Guideline for the Care and Use of
Laboratory Animals. Rats were acclimated for about 1 week before the
experiments.
Rats were randomly divided into four groups: Sham group (n = 6),
Sham + AVNP2 group (n = 6), C6 group (n = 6) and C6 + AVNP2
group (n = 6).
2.4. C6 model surgery and treatment
The rats were deprived of food and water for 12 h before surgery.
After being anesthetized with pentobarbital sodium (50 mg/kg,
intraperitoneal injection), the rat's scalp was incised along the top of the
head about 1–2 cm long to expose the top of the skull. A small hole with
diameter of 1 mm was drilled in the right 3 mm and posterior 0.5 mm of
the bregma. C6 cells (1 × 106/10 μl) were injected into the rat's cranial
cavity vertically at the depth of 5 mm from the dura mater with a speed
of 1 μl/min. The needle was retained for 10 min before withdrawal.
Then the skin was sutured. Rats of the Sham + AVNP2 and
C6 + AVNP2 groups were given AVNP2 the day after the surgery. The
AVNP2 suspension was injected into the body of rats at the dose of
3 mg/kg through the vena caudalis once a day for a week. Rats of the
Sham and C6 groups were given the equal amounts of normal saline
(NS) at the same time. On day 8 post-implantation, calliper measure-
ments were used to assess tumour size.
2.5. Weight recording and tumour specimens
From the day of modelling surgery, the weights of each group were
recorded at 10 a.m. daily. After the electrophysiological experiment,
the rats were killed by neck rupture, the skull was opened quickly and
the whole brain was removed. The transplanted tumours were re-
moved, and the volumes of the tumours were measured.
2.6. Terahertz (THz) radiation
The basic structure diagram of the THz imaging system is shown in
Fig. 2. An optically pumped THz gas laser (FIRL100, Edinburgh In-
struments Ltd.) was used. The maximum THz output power of this gas
laser can reach up to 150 mW at 2.52 THz. Gold-coated flat mirrors and
three off-axis parabolic reflectors were used to reflect and focus the THz
waves on samples and guide reflected waves to the detector. The focal
length of the parabolic reflector used was 2 in. and the F-number was 1.
Golay cells (GC-1P, Tydex Ltd.) were used as the detectors and the THz
wave was modulated as a sinusoidal signal using the chopper operating
at 50 Hz. The spatial resolution of this imaging system was
400 × 450 μm at 2.52 THz. The two dimensional (2D) movable sample
stages were used for THz images, and the scanning speed was 10 pixels/
s. The scanning step was set as 200 μm, and the temperature was kept
constant during all experiments.
2.7. Novel object recognition test (NORT)
The experiment was divided into two stages: the training stage and
the testing stage. In the training stage, the two same objects (A and B)
were placed in the 60 cm × 60 cm × 40 cm test box on the diagonal
line. The distance from the rats to the two objects was equal at the
beginning of the test. We recorded the exploratory behaviour of objects
A and B in over 10 min period. After 1 h, the test phase was carried out.
In this phase, object B was changed into object C, which was totally
Fig. 1. The TEM (transmission electron microscope) of nanoparticles: AVNP2.
The TEM was used to examine internal and amorphous structures of the AVNP2
particles. As arrows indicated, the effective nanoparticles of W-Ag-Cu inter-
metallics and other trace elements are shown as darkened sports with the
sample image, and they are wrapped with elemental carbon compounded sp2
graphene/graphite bonding structures. The metal intermetallics were dis-
tributed uniformly within the carbon nanostructured particles as white arrows
indicated their location and nano-sizes with the particle demine. The differ-
entiation and average sizes were measured in between 10 and 30 nm, which
proved the particles containing multiple elemental conjugations.
Fig. 2. Schematic of THz attenuated total reflection imaging setup. This method
with an isosceles triangle shaped silicon prism can provide information on the
interaction between the sample and evanescent wave traveling along a prism
surface. The surface information of the sample in close contact with a prism can
be acquired by two-dimensionally scanning of this prism moving in the x-y
plane.
J. Li, et al. Brain, Behavior, and Immunity xxx (xxxx) xxx–xxx
3
different from objects A and B. The exploratory time lasted for 10 min
and results were recorded. The time spent exploring a familiar object
(time 1, T1) and time spent exploring a novel object (time 2, T2) were
recorded. The recognition index (RI; RI = T2/(T1 + T2)) and dis-
crimination index (DI; DI = (T2 − T1)/(T2 + T1) (d'Isa et al., 2014)
were used to evaluate the cognitive level of rats. Both of them showed a
degree of preference of rats for new objects, while the former could take
into account the individual preferences of rats in the training stage
(d'Isa et al., 2014).
Besides, the distance travelled, total object exploration time and
velocity of movement were also calculated to validate the test results.
After each experiment, the inside of the reaction chamber was cleaned
up with 75% alcohol.
2.8. Open field test (OFT)
The bottom surface of the open field reaction chamber
(60 cm × 60 cm × 40 cm) was divided into 4 × 4 grids. The four grids
in the centre were defined as the central grids, and the 12 grids around
it were defined as the surrounding grids. The experiments were carried
out at 9:00 a.m. and the experimental site maintained a weak light
source. The rats were placed in the centre of the bottom of the reaction
chamber for 10 min. Meanwhile, the camera above the box recorded
the activity of the rats. The chamber was cleaned with 75% alcohol
after each experiment. The recording indices included the residence
time of animals in the central grids, and the mean arean speed was
calculated to validate the test results.
2.9. Electrophysiological experiment
The hippocampal synaptic plasticity between the Schaffer col-
laterals and CA1 pyramidal neurons of each rat was measured after the
OFT. The rat was anesthetized with 30% urethane (4 ml/kg) by in-
traperitoneal (i.p.) injection and was placed on the stereotaxic frames
(SR-6 N; Narishige, Japan). The rat’s scalp was incised, and a small hole
in the left side of the skull was drilled. The recording electrode was
inserted into the rat’s hippocampal CA1 region (3.5 mm posterior to the
bregma, 2.5 mm lateral to the midline, and 1.5–2.5 mm ventral below
the dura), and the bipolar stimulating electrode was inserted into the
rat’s hippocampal Schaffer collaterals region (4.2 mm posterior to the
bregma, 3.5 mm lateral to the midline, and 2–3.5 mm ventral below the
dura). The optimal stimulating intensity (range 0.3–0.5 mA) evoking a
response of 50% of its maximum amplitude was delivered at single-
pulse stimulation (stimulus pulse 0.2 ms at 0.03 Hz) to record a 20 min
baseline. After recording the baseline, a theta burst stimulation (TBS),
which was evoked by a Master 8 pulse stimulator (A.M.P.I., Jerusalem,
Israel) consisting of 30 trains of 12 pulses (200 Hz) at 5 Hz, was applied
to simulate long-term potentiation (LTP). Then, the single-pulse sti-
mulation was resumed at 60 s intervals for 1 h at the baseline intensity.
The initial data collections were analysed in Clampfit 10.0 (HEKA,
Germany).
2.10. Golgi-cox staining
The hippocampus was placed in Golgi-cox solution. The Golgi-cox
solution was renewed 3 days at a time. Then, the tissues were sliced into
150 μm sections. The slices were immersed in the following order: 6%
Na2CO3 20 min, distilled water 1 ~ 2 s, 70% ethanol 10 min, 90%
ethanol 15 min, anhydrous ethanol 20 min and xylene 20 min. Finally,
the slices were fixed on the slide with DPX and covered with glass. The
sections were observed by positive fluorescence microscopy. Dendritic
spine density was estimated by drawing segments about 20 um long
under a high power mirror (×1000) and counting the spine numbers
(Sholl et al., 1953). The dendritic spine density of pyramidal cells with
apical dendrites in the CA1 region was calculated. Then, we classified
the dendritic spines into four types based on their morphology:
mushroom (the head of a spine larger than 0.6 µm in diameter), stubby
(short spine with no head), thin (long spine with a small head, no larger
than 0.6 µm in diameter) and filopodia (long with no head) (Sorra and
Harris, 2000).
2.11. Western blot analysis
Meanwhile, the left hippocampal tissues of the rats in each group,
the peri-tumour tissues of the rats in the C6 group and C6 + AVNP2
group and the corresponding tissues in the same part of rats in the Sham
group and Sham + AVNP2 group were taken out. The tissues were
cracked and crushed on ice with pyrolysis solution (Beyotime
Biotechnology, Haimen, China). The treated tissues were centrifuged at
a speed of 12,000 rpm for 30 min at 4 °C and the precipitate was re-
moved. The protein contents of these tissues were determined by the
BCA method (Beyotime Biotechnology, Haimen, China). In the re-
maining supernatant, 4× loading buffer was added according to the
remaining supernatant at the ratio of 1:3, and the liquid was boiled for
15 min at 100 °C.
Equivalent amounts of protein (20 μg) from every group (n = 3)
were separated by SDS-PAGE gel electrophoresis. Afterwards, these
proteins were transferred to polyvinylidene fluoride (PVDF) mem-
branes (Milipore, USA). Then, the PVDF membranes were blocked by
5% skimmed milk powder for 1 h at RT. Subsequently, the membranes
were incubated with primary antibodies (anti-β-actin, 1:5000, Abcam;
anti-PSD-95, 1:2000, Abcam; anti-SYP, 1:2000, Abcam, anti-NF-ĸB p65,
1:500 Abcam; anti-VEGF, 1:2000, Abcam; anti-BDNF, 1:2000, Abcam;
and anti-IL-1β, 1:500; anti-IL-6, 1:500; anti-TNF-α 1:500; anti-inducible
nitric oxide synthase (iNOS), 1:200; and anti-COX-2, 1:200 – all pur-
chased from Santa Cruz Biotechnology) for a night at 4 °C. After being
incubated by the primary antibodies, the membranes were washed with
TBST and incubated with the secondary antibodies (1:5000) for 1 h at
RT. The membrane was cleaned again with TBST. The protein bands
were detected by chemiluminescent HRP substrate (Tanon Technology
Co., Ltd, Tanon 5500). Image J software (NIH, Bethesda, MD) was
applied to determine the quantification of the protein bands.
2.12. Enzyme-linked immunosorbent assay (ELISA)
The brain tissue around the glioma site and prefrontal lobe were
orderly collected and washed. Then, the homogenate was centrifuged at
6000 × g at 4 °C for 5 min. The supernatant was collected and prepared
for a succeeding assay. The levels of IL-6, IL-1β, and TNF-α in the su-
pernatants were measured following the manufacturer’s instructions by
using the rat Cloud-Clone Crop. ELISA kit (Houston, USA; IL-1β,
SEA563Ra, 96 T; IL-6, SEA079Ra, 96 T; TNF-α, SEA133Ra, 96 T).
2.13. Immunofluorescence staining
Immunofluorescence staining was done as previously described
(Zhang et al., 2017). Rats were perfused with 0.1 mol/l PBS (pH = 7.4)
to remove the blood. Then, the brain was cut into 8 μm thick slices on
the coronary plane. Slices were permeabilized in 0.3% Triton X for
5 min. Then, they were washed with PBS for 5 min twice. Afterwards,
the slices were blocked in 10% goat serum for 2 h at RT and were
incubated with primary antibodies (PSD95: 1:100, Abcam Ltd. USA;
SYP: 1:100, Abcam Ltd. USA) overnight at 4 °C. On the second day,
slices were incubated with secondary antibodies (Abcam 594-con-
jugated, USA) for 1 h at RT. Before microscopic examination, the nuclei
were stained with 4,6-diamidino-2-phenylindole (DAPI) for 5 min.
Fluorescent signals were notarized using a laser scanning confocal mi-
croscope (Olympus F1000, Japan). The number of immunofluorescence
labelled PSD-95-positive and SYP-positive cell bodies were quantified in
the cerebral cortex. There were four rats for each group, with four slices
of each rat. All immunofluorescence staining images were quantified by
ImageJ software.
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2.14. Data and statistical analysis
In this study, all data were shown as mean ± standard error of the
mean (SEM). Data from the behavioural tests, LTP recordings, Western
blot assay, ELISA assay, immunofluorescence staining and Golgi-cox
staining were analysed by two-way ANOVA with the post hoc test be-
hind. Data from the volume of tumours were analysed by t-test.
Statistical differences were considered when P < 0.05. The statistical
analyses were all calculated by using SPSS (version 16.0) software.
3. Results
3.1. Effects of AVNP2 on the weight of rats and the size of tumours
As shown in Fig. 3a, rats in all groups gained weight steadily within
eight days of the modelling, and there was no statistically significant
difference among the four groups (Fig. 3a, F = 0.2217,
P= 0.9999 > 0.05). The growth of the tumour in the brain is the main
reason for poor outcomes and deaths in both humans and experimental
animals (Ohgaki and Kleihues, 2005). To figure out the effects of
AVNP2 on the growth of C6-glioma in vivo; we separated the tumour
after the rats were sacrificed and measured the size of the tumour using
callipers. As shown in Fig. 3b and c, six glioma specimens from the C6
group and C6 + AVNP2 group are shown and the glioma size of the
C6 + AVNP2 group is clearly suppressed as compared with that of the
C6 group (Fig. 3b and c, P = 0.0276 < 0.05).
3.2. Thz ATR imaging to discriminate tumour region
To compare the normal and glioma brain tissue quantitatively, the
reflectivity divided by THz was used to reflect the intensity signal from
without and within the sample. Visual images, THz images, and re-
flectivity for fresh brain tissue with and without tumours are shown in
Fig. 4. Three images of brain tissue were obtained without tumour (a)
and with tumours (b and c). Each pixel was described by reflectivity.
The tumour region appeared darker in the visible images, which was
marked by dashed lines in the visual images. It was clearly seen that the
THz images for the normal brain tissue looked uniform and THz images
of glioma tissue showed obvious differences in the tumour region as
compared with the normal tissue, as shown in the red regions in the
THz images. The detailed profile of the reflectivity values along the
horizontal purple lines of the THz images were as shown in the re-
flectivity images (Fig. 4). The reflectivity values of the tumour region
were lower than 30%, whereas the reflectivity values for the normal
tissues were rarely lower than 30%. Considering all the samples, the
dynamic range of the reflectivity values for the normal and tumour
tissues were 27% ± 2% and 32% ± 3%, respectively.
3.3. Effects of AVNP2 on cognitive ability (NORT) of rats with glioma
The mode pattern is shown in Fig. 5a. In the training stage, the
exploration ratio among the groups showed no statistically significant
difference (Fig. 5b, F = 1.107, P = 0.3566 > 0.05). In the testing
stage, we calculated the RI (the formula: RI = T2/(T1 + T2)). There
was a statistically significant difference between the four groups by
two-way ANOVA test (Fig. 5c F = 11.72, P = 0.0001 < 0.001). Then,
through multiple comparisons test, we found that there was a statisti-
cally significant difference between the Sham group and C6 group
(Fig. 5c, F = 0.3533, P= 0.0026 < 0.01). Specifically, the rats of the
C6 group had some defects with memory and learning ability as com-
pared to the Sham group. Moreover, after treatment with AVNP2, the
RIs of rats in the C6 + AVNP2 group were obviously increased (Fig. 5c,
F = −0.4475, P = 0.0001 < 0.001). There was no statistically sig-
nificant difference between the Sham group and Sham + AVNP2 group
(Fig. 5c, F = 0.04924, P = 0.5769 > 0.05), which meant that this
drug had no side-effects with regard to the cognitive function of rats.
We also calculated the DIs of the four groups. There was a statistically
significant difference between the Sham group and C6 group (Fig. 5d,
F = 0.7067, P = 0.0026 < 0.01). Meanwhile, there was no statisti-
cally significantly difference between the Sham group and
Sham + AVNP2 group (Fig. 5d, F = 0.09849, P = 0.5769 > 0.05),
which corresponded to the results for the RIs. The distance travelled
and velocity of movement showed no difference among the four groups
(Fig. 5e, F = 1.298, P = 0.3026 > 0.05; Fig. 5g, F = 1.298,
P = 0.3026 > 0.05). There was a statistically significant difference
between the Sham group and C6 group in total object exploration time
(Fig. 5f, F = 3.190, P = 0.0459 < 0.05).
3.4. Effects of AVNP2 on exploratory behaviours (OFT) of rats with glioma
The OFT was carried out secondly, in order to remove the influence
of activity ability on the cognition results. We measured the arean speed
Fig. 3. Effects of AVNP2 administration on rats’
body weight gain in sham group, sham + AVNP2
group, C6 group and C6 + AVNP2 group every day.
Rats’ Body Weight was measured every day at noon
for eight consecutive days. It showed no statistic
difference among four groups, P > 0.05. Effects of
AVNP2 administration on C6 growth in vivo. Data
are expressed as mean ± SEM, n = 6 per group.
Fig. 3b: AVNP2 reduced the size of glioma growth in
the rat’s model. Fig. 3c: typical photos of tumours in
C6 group and C6 + AVNP2 group. Data represented
mean ± SEM, n = 3 per group, *P < 0.05.
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of rats in all groups during the test, and it was found that there was no
statistically significant difference among all groups for the OFT (Fig. 6a,
F = 0.1789, P = 0.9101 > 0.05). In this test, there was a statistically
significant difference for the time spent in the central compartment
among the four groups (Fig. 6b, F = 3.862, P= 0.0249 < 0.05). Rats
of the Sham group stayed longer in the central compartment as com-
pared to those of the C6 group (Fig. 6b, F = 19.42,
P = 0.0065 < 0.01). The performance of C6 model rats treated with
AVNP2 was much better than performance of C6 model rats without
intervention (Fig. 6b, F = -18.32, P = 0.0296 < 0.05). There was no
statistically significant difference for the time spent in the central
compartment between the Sham group and Sham + AVNP2 group
(Fig. 6b, F = 4.317, P = 0.4603 > 0.05).
3.5. Effects of AVNP2 on electrophysiological experiments of rats with
glioma
As shown in Fig. 7a, before TBS, the baseline fEPSPs of all four
groups were very stable under low-frequency stimulation. After the TBS
stimulation, the slopes of the fEPSPs were significantly increased within
the following 60 min, except the rats in the C6 group that were lower
than the other groups (Fig. 7a). The slopes of the fEPSPs for LTP in the
C6 group were apparently decreased as compared to the Sham group
(Fig. 7b, F = 16.5796, P < 0.0001). AVNP2 up-regulated the fEPSPs
in the C6 + AVNP2 group (Fig. 7b, F = 15.7325, P < 0.0001). In
addition, there was no statistically significant difference between the
Sham group and Sham + AVNP2 group (Fig. 7b, F = 2.1761,
P > 0.05), which meant AVNP2 did not harm synaptic plasticity.
3.6. Effects of AVNP2 on the neuronal dendritic spine density in CA1 region
of rats with glioma
Golgi-cox stained CA1 pyramidal neurons are shown in Fig. 8a. The
statistical analysis showed that the density of the dendritic spines of the
pyramidal neurons in the CA1 region of C6 model rats was obviously
less than those of the Sham group (Fig. 8b, F = 17.40, P < 0.0001).
Meanwhile, the density of dendritic spines was significantly increased
in the C6 + AVNP2 group as compared to those of the C6 group
(Fig. 8b, F = −2.272, P = 0.005 < 0.01).
We also compared the frequencies of the four spine types (stubby,
mushroom, thin and filopodia) among the four groups. The frequency of
stubby spines (mature type) was significantly decreased in the C6 group
(29.3%) (Fig. 8c) as compared with the Sham group (42.4%,
P < 0.001), Sham + AVNP2 group (40.4%, P < 0.001) and
C6 + AVNP2 group (40.4%, P < 0.001) respectively. On the other
hand, the frequency of thin spines (immature type) were increased in
the C6 group (37.1%) (Fig. 8c) as compared with the Sham group
(22.9%, P < 0.001), Sham + AVNP2 group (22.8%, P < 0.001) and
C6 + AVNP2 group (21.3%, P < 0.001). These results showed a defect
of the mature dendritic spines in the rats of the C6 group and an im-
provement of the mature dendritic spines in rats of the other groups. All
the above suggested that AVNP2 administration prevented the dendritic
impairment induced by C6 cells.
3.7. AVNP2 administration increased the expression of synaptic related
proteins
PSD-95 and SYP are the two main synaptic-related proteins. As
shown in Fig. 9b and d, AVNP2 administration (Sham + AVNP2 group
and C6 + AVNP2 group) elevated the expression levels of SYP and PSD-
95. (Fig. 9b, F = 7.908, P = 0.0089 < 0.01; Fig. 9d, F = 14.81,
P = 0.0013 < 0.01). It showed that the expression levels of SYP and
PSD-95 were suppressed in the hippocampus of rats in the C6 group as
compared with the Sham group (Fig. 9b, F = 0.2057,
P= 0.0301 < 0.05. Fig. 9d, F = 2.236, P= 0.0014 < 0.01), and the
SYP and PSD-95 proteins were relatively elevated in the C6 + AVNP2
group (Fig. 9b, F = -0.1513, P= 0.0023 < 0.01. Fig. 9d, F =−1.273,
P = 0.0393 < 0.05). There was no statistically significant difference
between the Sham group and Sham + AVNP2 group (Fig. 9b,
P = 0.4518 > 0.05; Fig. 9d, P = 0.521 > 0.05).
Fig. 4. The results of terahertz (THz) radiation test. Visual imaging, THz imaging and the reflectivity at the horizontal purple line of THz images about freshly excised
brain tissues without (a) and with (b, c) tumours. The high absorption regions of THz wave are tumour regions, as the red areas shown in THz images. The value of
the reflectivity of the tumour regions was less than 30%, corresponding to the dotted line shown in reflectivity images.
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3.8. AVNP2 administration modulated the inflammation in brains of C6-
bearing rats
In order to detect whether inflammation played a crucial role in the
deficiency of the cognitive status of the rats, we tested the expression of
iNOS (130 kDa) and COX-2 (68 kDa). As shown in Fig. 9e and f, COX-2
and iNOS were increased in the peri-tumour tissue of rats in the C6
group as compared to those of the Sham group (Fig. 9e, F = −1856,
P < 0.0001; Fig. 9f, F = −327.3, P < 0.0001) and the levels of COX-
2 and iNOS were reduced in the C6 + AVNP2 group (Fig. 9e, F = 1014,
P < 0.0001; Fig. 9f, F = 116.8, P = 0.0478 < 0.05), which meant
that AVNP2 improved the inflammation in the brain of the rats. As a
result, AVNP2 could prevent the injury of neurons in the hippocampus
by reducing the inflammatory proteins and improving the cognitive
conditions of rats. There were no statistically significant differences
between the Sham group and Sham + AVNP2 group in the expression
of COX-2 and iNOS (Fig. 9e, F = 1.274, P = 0.1107 > 0.05; Fig. 9f,
F = 12.17, P = 0.1023 > 0.05).
3.9. AVNP2 administration suppressed the NF-ĸB pathway in rats with
glioma
In cerebral peri-tumour tissue, inflammation was accompanied by
the activation of the NF-ĸB pathway. In order to know whether AVNP2
modulated local inflammation by activating the NF-ĸB pathway, we
detected the expression of related proteins (Fig. 10a). Western blotting
Fig. 5. Effects of AVNP2 administration on novel object recognition test. a: the mode pattern of novel object recognition test. b: the exploration ratio (Ratio 1) in
training stage shows no difference among four groups. P > 0.05. c: recognition index (RI) in testing stage showed that there exists statistic difference between sham
group and C6 group, **P < 0.01; C6 group and C6 + AVNP2 group, **P < 0.01. d: the graph shows the discrimination indexes (DI), the sham group compared to C6
group, ***P < 0.001; the sham group compared to C6 + AVNP2 group, P > 0.05. e: the graph shows no difference among four groups in distance traveled,
P > 0.05. f: the Total Object Exploration Time results show the statistic difference between sham group and C6 group, *P < 0.05; no difference among other
groups, P > 0.05. g: the graph shows no difference among four groups in Velocity Of Movement, P > 0.05. Data of Fig. b, c, d, e, f, g represent mean ± SEM, n = 6
per group.
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results showed that the level of phosphorylated NF-ĸB p65 was ap-
parently different among the four groups (Fig. 10b, F = 15.54,
P = 0.0011 < 0.01). The LSD analysis showed that the level of
phosphorylated NF-ĸB p65 was up-regulated in the C6 group as com-
pared with the Sham group (Fig. 10b, F = 8.177, P= 0.0027 < 0.01),
while this level was down-regulated in the C6 + AVNP2 group
(Fig. 10b, F = 4.175, P = 0.0026 < 0.01). There was no statistically
significant difference between the Sham group and Sham + AVNP2
group (Fig. 10b, F = 1.151, P = 0.0950 > 0.05). Besides, one-way
ANOVA analysis showed that there was an apparent difference in the
levels of IL-1β, IL-6, TNF-α and BDNF between the four groups
(Fig. 10c, F = 7.631, P = 0.0099 < 0.01; Fig. 10d, F = 9.894,
P = 0.0046 < 0.01; Fig. 10e, F = 16.07, P = 0.0009 < 0.001;
Fig. 10f, F = 7.139, P = 0.0119 < 0.05). AVNP2 administration de-
creased the level of neuro-inflammation in peri-tumour tissue in
C6 + AVNP2 group compared to that of C6 group (Fig. 10c, F = 36.14,
P = 0.0022 < 0.01. Fig. 10d, F = 59.99, P = 0.0080 < 0.01.
Fig. 10e, F = 55.59, P = 0.0073 < 0.01). AVNP2 administration in-
creased the level of BDNF in the C6 + AVNP2 group as compared with
the C6 group (Fig. 10f, F = -25.61, P= 0.0186 < 0.05). These results
tentatively reminded us that AVNP2 administration may down-regulate
the neuro-inflammatory response by suppressing the NF-ĸB pathway.
Furthermore, it may improve the level of cognition. Moreover, we
tested the expression of VEGF (Fig. 10g), which represented the level of
angiogenesis in the peri-tumour tissue of the brains of rats. We found
that the C6 group had a higher level expression of VEGF as compared to
Fig. 6. Effects of AVNP2 administration on open field test. a: arean speed was calculated to remove the effect of speed on the results analysis. P > 0.05. b: Effects of
AVNP2 administration on open field test. The graph shows the statistic difference between sham group and C6 group, *P < 0.05; C6 group and C6 + AVNP2 group,
*P < 0.05. Data represent mean ± SEM, n = 6 per group.
Fig. 7. Effects of AVNP2 administration on LTP. a:LTP in the CA3 region was recorded, TBS was used to induce the LTP. b: Mean fEPSP slope between 45 and 60 min
was regarded as responses, statistic difference was showed between C6 group and sham group/sham+ AVNP2 group/C6 + AVNP2 group, ***P < 0.001. c: Effect of
AVNP2 on LTP in hippocampal neurons. Data represent mean ± SEM, n = 6 per group.
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that of the Sham group (Fig. 10h, F = 6.959, P = 0.0084 < 0.01),
while AVNP2 suppressed it in the C6 + AVNP2 group (Fig. 10h,
F = 4.370, P = 0.0155 < 0.05). There was no statistically significant
difference between the Sham group and Sham + AVNP2 group
(Fig. 10h, F = -2.864, P = 0.1075 > 0.05).
3.10. AVNP2 administration suppressed the levels of pro-inflammatory
cytokines in rats with glioma
Based on the Western blotting results, we detected the levels of IL-
1β, IL-6 and TNF-α by using ELISA in the peri-tumour tissue and pre-
frontal lobe (Fig. 11a, b, c, d, e and f). The ELISA results showed the
levels of IL-1β, IL-6 and TNF-α were statistically significant different
among the four groups (Fig. 11a, b and c; F = 8.939,
P = 0.0022 < 0.01; F = 306.8, P = 0.0001; F = 13.55,
P = 0.0017 < 0.01, respectively). The LSD analysis showed that the
level of IL-1β, IL-6 and TNF-α were increased in the C6 group as
compared with the Sham group in peri-tumour tissue (Fig. 11a, b and c;
F = 41.96, P = 0.0019 < 0.01; F = 71.87, P = 0.0001; F = 18.87,
P= 0.0024 < 0.01, respectively), while these levels were decreased in
the C6 + AVNP2 group (Fig. 11a, b and c; F = 33.07,
P = 0.0024 < 0.01; F = 64.52, P = 0.0001; F = 17.16,
P = 0.0073 < 0.01, respectively). There was no statistically sig-
nificant difference between the Sham group and Sham + AVNP2 group
(Fig. 11a–c; F = 1.298, P = 0.8355 > 0.05; F = 21.46,
P = 0.0890 > 0.05; F = 1.411, P = 0.8295 > 0.05, respectively).
What’s more, we also detected these three pro-inflammatory factors in
the prefrontal lobe, which plays an important role in emotion regula-
tion but is farther from the glioma as compared to peri-tumour tissue.
The ELISA results showed the level of IL-1β was statistically significant
different among the four groups (Fig. 11d, F = 4.761,
P = 0.0207 < 0.05), but there were no statistically significant dif-
ferences for IL-6 and TNF-α among the four groups (Fig. 11e and f;
F = 2.655, P = 0.0754 > 0.05; F = 3.120, P = 0.0663 > 0.05,
respectively). The LSD analysis showed that the level of IL-1β was in-
creased in the C6 group as compared with the Sham group in the pre-
frontal lobe (Fig. 11d, F = 9.747, P= 0.013 < 0.05) and decreased in
the C6 + AVNP2 group in the prefrontal lobe (Fig. 11d, F = 8.102,
P = 0.025 < 0.05).
3.11. The expression of synaptic-related protein changes by
immunofluorescence
Immunofluorescence was carried out to validate the neuro-related
protein expression changes (Fig. 12c and d). We found a tendency to-
ward a decreasing in the intensities of PSD-95 (Fig. 12a, F = 2.206,
P = 0.0234 < 0.05) and SYP (Fig. 12b, F = 4.473,
P = 0.0250 < 0.05) as compared to the Sham group in the cerebral
cortex. However, AVNP2 administration ameliorated the reduced in-
tensities of PSD-95 (Fig. 12a, F = 1.038, P= 0.0459 < 0.05) and SYP
Fig. 8. Effects of AVNP2 administration on hippocampal dendritic morphology. According to morphology, dendritic spines were classified into four types: mush-
room, stubby, thin and filopodia. a: The microscope shows the photographs of Golgi stained hippocampal CA1 neuron region. The different types of dendritic spines
on the dendrites (indicated by black arrows) are shown. Scalebar, 10 μm. b: The density of dendritic spines of Sham group, Sham + AVNP2 group, C6 group and
C6 + AVNP2 group. c: The frequencies of different spine types were calculated. Data represented mean ± SEM, n = 6 per group. *P < 0.05, **P < 0.01,
***P < 0.001.
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(Fig. 12b, F = 6.208, P = 0.0158) as compared to the C6 + AVNP2
group. There was no statistically significant difference between the
Sham group and Sham+ AVNP2 group with regard to the expression of
PSD95 and SYP (Fig. 12a and b; F = 1.131, P = 0.0705 > 0.05;
F = 1.476, P = 0.9897 > 0.05, respectively). These results were
correlated with the Western blotting assay results (Fig. 9).
4. Discussion
GBM is one of the most malignant tumours in the central nervous
system. An unoptimistic prognosis still exists for even after receiving
systematic treatment, with a 5-year survival rate of 5% (Ostrom et al.,
2015). The resistance of glioma cells to chemotherapeutic drugs makes
it much harder for doctors to control the progression of the tumour.
Thus, it is vital for researchers to create new drugs or drug delivery
systems to destroy the tumour cells (Saalik et al., 2019). Due to their
integrated good physical and chemical properties, NPs have attracted
the attention of researchers. In our research, we chose AVNP2 as an
anti-inflammatory drug in C6 model rats. AVNP2 proved to inhibit the
inflammation induced by viruses in vitro. Many studies had proved the
gratifying results about tumour growth inhibition by using NPs or NP-
delivering systems in animal experiments (Del Sol-Fernandez et al.,
2019; Yu et al., 2019; Liang et al., 2018). However, the underlying
mechanisms in NP therapy, especially the change of tumour-associated
inflammation inside the tumour environment and peri-tumour tissue,
haven’t been explained clearly (Ovais et al., 2019). We wanted to in-
vestigate whether AVNP2 had a similar effect on gliomas. This time, we
found that AVNP2 could not only modulate the tumour associated in-
flammation but also the levels of inflammation-related proteins such as
IL-1β, IL-6, TNF-α and NF-ĸB, which all together play an indispensable
role in the formation, growth, infiltration and metastasis of gliomas
(Zhu et al., 2017).
Among the inflammatory-related proteins mentioned before, nu-
merous clinical investigations have suggested that their expression in
gliomas, peri-glioma tissue and cerebrospinal fluid were significantly
higher than that in normal tissue, and the expression level has a positive
relationship with the grade of glioma (Shan et al., 2015; Lang et al.,
2018; Thompson et al., 2016; Zou et al., 2019). In our study, we tested
the level of inflammation-related proteins in peri-tumour tissue using
the Western blotting assay and ELISA test, which could be used as a
detection marker for treatment. We found the expression in the C6
group was higher than in the normal control group. However, AVNP2
decreased them in the C6 + AVNP2 group and promoted a better TME.
A recent study showed that IL-6, IL-1β and TNF-α could enhance the
proliferation and anti-apoptotic ability of glioma stem cells (Wang
et al., 2009). Da Silva et al used the flavonoid rutin and its aglycone
Fig. 9. Effects of AVNP2 administration on
synaptic-related and inflammation-related
protein. The Western blot assay showed that
the levels of PSD-95 from hippocampal
tissue of rats of C6 groups were reduced
significantly compared with all other groups
(Fig. 9b, *P < 0.05, **P < 0.01).
However, protein expression in C6 group
treated with AVNP2 had no significant dif-
ference with sham group and
sham + AVNP2 group (Fig. 9b, P > 0.05).
The familiar results could be seen in SYP
(Fig. 9d). The Western blot assay showed
that the levels of COX-2 and iNOS from peri-
tumor tissues of C6 groups were increased
significantly compared with all other groups
(Fig. 9e, *P < 0.05, ***P < 0.001).
However, protein expression in
C6 + AVNP2 group had no significant dif-
ference with Sham+ AVNP2 group (Fig. 9e,
P > 0.05). The familiar results could be
seen in iNOS (Fig. 9f). Data represented
mean ± SEM, n = 3 per group, *P < 0.05
***P < 0.001.
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Fig. 10. Effects of AVNP2 administration on NF-ĸB pathway related protein. The Western blot assay showed that the levels of p-P65 from peri-tumor tissue of rats of
C6 groups were increased significantly compared with all other groups (Fig. 10b, *P < 0.05, ***P < 0.001). However, protein expression in Sham group treated
with AVNP2 had no significant difference with Sham+ AVNP2 group (Fig. 10b, P > 0.05). The familiar results could be seen in IL-1β, IL-6, TNF-α (Fig. 10c–e). The
level of BDNF was decreased in C6 group compared with other groups (Fig. 10f, *P < 0.05, **P < 0.01). The results showed that VEGF was evaluated in C6 group
(Fig. 10g, *P < 0.05, **P < 0.01). And there was no difference between sham, sham + AVNP2 and C6 + AVNP2 groups (Fig. 10g, P > 0.05). Data represented
mean ± SEM, n = 3 per group, *P < 0.05, **P < 0.01, ***P < 0.001.
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quercetin to modulate inflammation in the microglia and inhibit the
proliferation of gliomas (da Silva et al., 2019).
Moreover, the inflammatory response could also be reflected by
COX-2, iNOS and VEGF, one of the most vital known pro-angiogenic
factors. We tested them in peri-tumour tissue. They have been claimed
by considerable studies to be inextricably linked with glioblastoma
(Myung et al., 2010; D'Alessandris et al., 2015). They affected the
genesis of glioma and enhanced multifaceted biological capabilities by
promoting angiogenesis and prognosis (Hara and Okayasu, 2004).
Western blotting assay of COX-2, iNOS and VEGF did not totally prove
the anti-angiogenesis function of AVNP2 on gliomas but gave us a hint,
which needs to be investigated deeper by means of ELISA and the tu-
bule formation test in vivo and in vitro (Chen et al., 2016). The acti-
vation or suppression of endothelial cells (ECs), which play an im-
portant part in tumour angiogenesis, are worthy of study and discussion
too (Liu et al., 2018). In our experiment, results corresponded to the
inflammation-related proteins mentioned before. With the administra-
tion of AVNP2, the levels of them were subdued in peri-tumor tissue.
The down-regulation of inflammation-related proteins in peri-tumour
tissue may be the reason for inhibition of TAMs by AVNP2, which are
recruited by gliomas. However, it couldn’t function as a protector in
humans and secretes inflammatory cytokines to promote tumour cell
proliferation inversely (Yang et al., 2017). Hwang JS et al. considered
that IL-6, TNF-α, iNOS and COX-2 were glioma-secreted soluble factors
that could stimulate the activation of TAMs (Hwang et al., 2016).
Up to now, the TME, especially tumour associated inflammation and
the interaction between tumour cell and immune cells is not very clear.
It is universally accepted that glioma-secreted soluble factors and TME-
secreted soluble factors all take part in the formation of the TME, and
promote the proliferation of tumour cells (Barkal et al., 2019). What has
been mentioned is that much research has focused on the micro-en-
vironment inside the glioma itself (Thorsson et al., 2018; Platten et al.,
2018). However, peri-tumour inflammation is worth observing too,
which happens in the normal brain region and directly influences
normal brain function. Many years ago, some researchers and clinicians
found patients diagnosed with cancer would suffer from psychiatric
disorders, especially brain tumours. At the time, psychiatric disorders
were partly blamed on the “paraneoplastic syndrome” (Benros et al.,
2009; Dalton et al., 2009). Paraneoplastic syndromes are referred to as
symptom complexes that occur in patients with cancer that cannot be
readily explained by local or distant spread of the tumour. Nowadays,
with a deeper understanding of the biological characteristics of gliomas,
researchers have found that the interaction between gliomas and nerve
cells was much more complex than we thought before. Tumour-derived
factors, such as IL-6 and TNF-α, could implicate the hippocampus,
prefrontal lobe and other brain regions (Walker Ii et al., 2017; Yang
et al., 2014), and tumours could even form “synaptic-like” connections
with nerve cells (Barria, 2019; Venkatesh et al., 2019). All these
couldn’t be explained just by the physical effect (i.e., mass effect of the
brain tumour), but the biological effect (i.e., complex molecular inter-
action between the brain and tumour cells). Researchers have explored
the relationship between tumours and cognition, and tumour-asso-
ciated inflammation has attracted great interest. The pro-inflammatory
and inflammatory factors, such as IL-6, IL-1β and TNF-α, secreted by
gliomas play a vital role in the implication that brain functional
structures directly cause psychiatric disorders. In brief, the
Fig. 11. The effects of AVNP2 administration on pro-inflammation-related protein measured by ELISA test. The ELISA test showed that the levels of IL-1β, IL-6 and
TNF-α from brain tissue around glioma and prefrontal lobe of rats of C6 group were increased significantly compared with all other groups (Fig. 11a–c, **P < 0.01,
****P < 0.0001), no significant difference was found between Sham group and Sham + AVNP2 group (Fig. 11a–c, P > 0.05). The level of IL-1β from prefrontal
lobe of rats of C6 group was increased significantly compared with all other groups (Fig. 11d *P < 0.05), no significant difference was found between Sham group
and Sham + AVNP2 group (Fig. 11d, P > 0.05). The levels of IL-6 and TNF-α from prefrontal lobe of rats showed no statistical difference among four groups
(Fig. 11e, f P > 0.05). Data are expressed as mean ± SEM, n = 4 per group, *P < 0.05, **P < 0.01, ****P < 0.0001.
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inflammation in the tumour associated environment has crucial effects
on tumour proliferation and growth, as well as the normal functions of
the brain. The better the inflammation is, the better the outcome
(Fig. 13).
In this experiment, we used the classic glioma model- a C6 cell-
based glioma rat model (Nagano et al., 1993; Chicoine and Silbergeld,
1995). Next, we measured the tumour volume of gliomas in C6 model
rats (Braganhol et al., 2009). The volume obviously decreased after
treatment with AVNP2, which proved that AVNP2 could indeed inhibit
the growth of the tumour through modulation of the micro-environ-
ment. Many researchers have found that the tumour growth could be
decreased by modulating inflammation (Ferrandon et al., 2015), which
was also confirmed by our results. Besides, we obtained THz ATR to
help us to define the margin of gliomas with imaging of freshly excised
brain tissues with and without tumours at 2.52 THz. We chose it be-
cause THz ATR intensity imaging could be employed as a com-
plementary technique, allowing surgeons to determine tumour regions
with a label-free and diagnostic imaging method in real time. It has
more important clinical significance than H&E staining (Reid et al.,
2011; Parrott et al., 2011; Ji et al., 2016).
What should not be neglected is that emotional abnormalities and
cognitive changes during the course of disease are among the various
factors leading to cognitive impairment and immune and inflammatory
factors play a key part. In our previous experiments, it was confirmed
that cognitive abnormalities of glioma model rats occurred (Wang et al.,
2011), which was the same in our preliminary work. Increasing studies
have also shown that the release of inflammatory factors and activation
Fig. 12. The effects of AVNP2 administration on synaptic-related protein tested by Immunofluorescence staining test. Immunofluorescence staining test showed the
protein intensity of PSD-95 (Fig. 12a) & SYP (Fig. 12b) across Sham, Sham + AVNP2, C6 and C6 + AVNP2 groups in cerebral cortex region. Images of im-
munofluorescence staining of PSD-95 [1:1000] (red) and SYP [1:1000] (red) with DAPI (blue) in Sham (Fig. 12c(1–6)), Sham+ AVNP2 (Fig. 12d(1–6)), C6 (Fig. 12e
(1–6)) and C6 + AVNP2 (Fig. 12f(1–6)) group. Quantitative intensity measurement showed a tendency of decrease in PSD-95 (*P < 0.05) and SYP (*P < 0.05)
signal in C6 group compared with Sham group (Fig. 12a, b), and the reductions were removed in PSD-95 (*P < 0.05) and SYP (*P < 0.05) with AVNP2
administration in C6 + AVNP2 group (Fig. 12a, b). Data are expressed as mean ± SEM, n = 4 per group, *P < 0.05, **P < 0.01.
Fig. 13. Pattern diagram showed the multiple impacts of AVNP2 on C6 glioma
model rats. Arrow (1) indicated that the research went from macro- into micro-
dimensions and Arrow (4) indicated that the research went from micro- into
macro- dimensions. The double sided Arrow (2) showed that glioma could in-
duce inflammation by releasing pro-inflammation cytokines in peri-tumour
tissues, and the pro-inflammation cytokines could promote glioma proliferation
in return. Arrow (3) indicated that these cytokines could damage synaptic
function. Arrow (5) indicated that AVNP2 could suppress the level of pro-in-
flammation cytokines and protects against cognitive impairment.
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of related signalling pathways promote cognitive impairment in pa-
tients with brain tumours (Mostofa et al., 2017).
Campos-Pires et al explored the relationship between chronic neuro-
inflammation and survival after traumatic brain injury in mice
(Campos-Pires et al., 2019). The role of inflammation in Alzheimer
disease (AD) and some psychological disorders has been studied much
deeper than in other fields (Heppner et al. et al., 2015; Murata et al.,
2020). Walker et al. found that cancer-induced systematic inflammation
played an important role in cognitive impairment (Walker et al., 2018).
The brain tumour induced inflammation, especially in the peri-tumour
brain region, has resemblances with these. In this study, we suppressed
the inflammation induced by gliomas, so we inferred that the cognition
level of C6-bearing rats can be improved by AVNP2 administration. We
implemented several of the following approaches: neuro-related pro-
teins, staining of dendritic spines, electrophysiology tests and beha-
vioural experiments, from the micro- to the macro-level, to evaluate the
cognition level all-around.
Researches have proved the relationship between inflammation and
both SYP and PSD-95. Inflammation could decrease the levels of SYP
and PSD-95 (Yang et al., 2018) (Zong et al., 2012), but few have gone
deeper into the tumour-induced inflammation. Hao et al found that C6
gliomas could lead to down-regulation of SYP, but no significant dif-
ference was found in the expression of PSD-95 (Hao et al., 2018).
However, in our experiment, SYP and PSD-95 were both down-regu-
lated in C6-bearing rats by the Western blotting assay and immuno-
fluorescence staining test respectively, while the AVNP2 could reverse
this by suppressing the pro-inflammation cytokines level, which were
confirmed by Western blotting assay and ELISA test respectively. We
considered that the different results happened because of the different
experimental design. In Hao’s experiment, the interval between C6 cell
xenograft with tumour specimen collection was five days, however, in
our experiment, the interval was eight days. We could reasonably as-
sume that SYP is more sensitive to damage from inflammation than
PSD-95. As shown in the immunofluorescence staining test, the degree
of decrease with SYP was larger than PSD-95, and this was correlated
with results of Western blotting. These synaptic plasticity-related mo-
lecules explained the improvement of neurocognitive and learning-
memory function in rats with gliomas on the micro-level, which in-
dicated that AVNP2 could inhibit the biological functions of gliomas by
inhibiting inflammation and angiogenesis, thus enhancing the cognitive
levels of GBM model rats.
In order to know the cognitive function at a histological level, we
performed Golgi-cox staining. Firstly, in our experiment, the results
apparently showed that AVNP2 could increase dendritic spine density
in the hippocampus and further enhance the learning-memory ability of
glioma model rats. Secondly, we confirmed the improved inflammation
reaction in the same local tissue. Inflammation induces oedema and
local hypertension, all if which could damage the dendritic spines.
Decades ago, researchers found significant pathological changes in peri-
tumour brain tissue, such as swollen dendrites, disarray of microtubules
and decreased dendritic spine density. However, due to incomprehen-
sion of the neuro-immune system, no one had related these to tumour
associated inflammation in local tissue (Spacek, 1987). This time, we
inferred that AVNP2 improved cognitive function on a histological level
(indirectly) by suppressing the tumour-associated inflammation in local
areas. With the administration of AVNP2, the inflammation was con-
trolled and injury to the hippocampus was relieved.
Accordingly, LTP was measured in the present study. We know that
the slopes of fEPSPs have a positive correlation with synaptic trans-
mission and memory in physiology. The LTP measurements in this
study were consistent with the performance of memory, which was in
line with our previous “microcosmic” results. The negative effect, tu-
mour associated inflammation, on LTP was apparently impeded by the
administration of AVNP2, which suggested that synaptic plasticity was
remarkably enhanced in the hippocampus after modulating the level of
tumour associated inflammation. In a word, the synaptic function of the
hippocampus was significantly improved after treatment with AVNP2
in glioma model rats. What’s more, the C6-bearing rats performed
better than rats without proper treatment in both the OFT and the
NORT, which indicated the cognitive impairment caused by gliomas
was ameliorated by AVNP2 on a behavioural test level.
5. Conclusion
In summary, our results indicated that AVNP2 not only depressed
the local inflammation and angiogenesis in peri-tumour tissue but also
inhibited the growth of gliomas in in vivo animal tests. We obtained
gross tumour specimens and calculated the tumour volume reduction
and used THz ATR imaging to identify the margins of gliomas. Our
work indicated that AVNP2 could modulate tumour-associated in-
flammation, depress the size of gliomas and eventually alleviate the
cognitive levels of C6-bearing rats. Our results also demonstrated an
important and significant enlightenment from a preclinical and clinical
medicine perspective for further research into cancer solutions.
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